Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support

Inclusion Criteria

• •Only patients having signed the consent form regarding study information, data transfer and data use
• •The patients suffer from idiopathic Parkinson's Disease (iPD) treated with a combination of L-dopa or another oral iPD drug and Neupro® for at least one month
• •The patients require caregiver support documented as per medical records (e.g. based on German level of care intensity 1 or greater)
• •The decision to prescribe Neupro® must have been made by the physician independent of his/her decision to include the patient in the study
• •And according to Summary of Product Characteristics (SmPC): Hypersensitivity to the active substance or to any of the excipients, magnetic resonance tomography (MRT) or cardioversion